Novel bivalent securinine mimetics as topoisomerase I inhibitors12. Issue 2 (17th January 2017)

• Record Type: Journal Article
• Authors: Hou, Wen; Lin, Hui; Wang, Zhen-Ya; Banwell, Martin G.; Zeng, Ting; Sun, Ping-Hua; Lin, Jing; Chen, Wei-Min
• Is Part Of: MedChemComm. Volume 8:Issue 2(2017)
• Page Start: 320
• Page End: 328
• Publication Date: 2017-01-17
• Subjects: Pharmaceutical chemistry -- Periodicals; 615.19
• DOI: 10.1039/c6md00563b
• Languages: English
• ISSNs: 2040-2503

Abstract

Abstract : A series of novel bivalent securinine mimetics incorporating different linkers between C-15 and C-15′ were synthesized and their topoisomerase I (Topo I) inhibitory activities evaluated. Abstract : A series of novel bivalent securinine mimetics incorporating different linkers between C-15 and C-15′ were synthesized and their topoisomerase I (Topo I) inhibitory activities evaluated. It was thus revealed that mimeticR2 incorporating a rigid m -substituted benzene linker exhibits Topo I inhibitory activity three times that of parent securinine. Comprehensive structure–activity relationship analyses in combination with docking studies were used to rationalize the potent activity of these bivalent mimetics. Mechanistic studies served to confirm the deductions arising from docking studies that the active bivalent mimetics not only inhibited complexation between Topo I and DNA but also stabilized the Topo I–DNA complex itself.